Greenland John R, Geiben Ralf, Ghosh Sharmistha, Pastor William A, Letvin Norman L
Division of Viral Pathogenesis, Harvard Medical School, Beth Israel Deaconess Medical Center, 41 Avenue Louis Pasteur, Boston, MA 02215, USA.
J Immunol. 2007 May 1;178(9):5652-8. doi: 10.4049/jimmunol.178.9.5652.
Particularly potent cellular or humoral immune responses are needed to confer protection in animal models against such pathogens as HIV/SIV, Mycobacterium tuberculosis, and malarial parasites. Persistent, high-level vaccine Ag expression may be required for eliciting such potent and durable immune responses. Although plasmid DNA immunogens are being explored as potential vaccines for protection against these pathogens, little is known about host factors that restrict long-term plasmid DNA vaccine Ag expression in vivo. We observed rapid damping of transgene expression from a plasmid DNA immunogen in wild-type, but not in T cell-deficient mice. This damping of Ag expression was temporally associated with the emergence of Ag-specific cellular immune responses. A requirement for Fas and the appearance of apoptotic nuclei at the site of vaccine inoculation suggest that T cells induce Fas-mediated apoptosis of plasmid DNA vaccine Ag-expressing cells. These studies demonstrate that high levels of in vivo Ag expression are associated with high-frequency cellular immune responses that in turn rapidly down-regulate vaccine Ag expression in vivo. These findings argue that it may not be possible to maintain persistent, high-level production of vaccine Ag in vivo to drive persistent immune responses as long as vaccine Ag production can be limited by host immune responses.
在动物模型中,针对诸如HIV/SIV、结核分枝杆菌和疟原虫等病原体提供保护需要特别强效的细胞免疫或体液免疫反应。可能需要持续的高水平疫苗抗原表达来引发如此强效且持久的免疫反应。尽管质粒DNA免疫原正在作为针对这些病原体的潜在疫苗进行探索,但对于限制质粒DNA疫苗抗原在体内长期表达的宿主因素知之甚少。我们观察到,野生型小鼠中质粒DNA免疫原的转基因表达迅速衰减,但在T细胞缺陷小鼠中则不然。抗原表达的这种衰减在时间上与抗原特异性细胞免疫反应的出现相关。对Fas的需求以及疫苗接种部位凋亡细胞核的出现表明,T细胞诱导表达质粒DNA疫苗抗原的细胞发生Fas介导的凋亡。这些研究表明,体内高水平的抗原表达与高频细胞免疫反应相关,而高频细胞免疫反应反过来又会迅速下调体内疫苗抗原的表达。这些发现表明,只要疫苗抗原的产生会受到宿主免疫反应的限制,就可能无法在体内维持持续的高水平疫苗抗原产生以驱动持久的免疫反应。